312 related articles for article (PubMed ID: 34578258)
1. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study.
Georgakopoulou VE; Garmpis N; Damaskos C; Valsami S; Dimitroulis D; Diamantis E; Farmaki P; Papageorgiou CV; Makrodimitri S; Gravvanis N; Velonias S; Sklapani P; Trakas N; Antoniou EA; Kontzoglou K; Nikolidakis L; Damaskou Z; Syllaios A; Marinos G; Vogiatzi G; Korrou GE; Kyriakos G; Quiles-Sanchez LV; Patsouras A; Lamprinos D; Stelianidi A; Savvanis S; Garmpi A
In Vivo; 2021; 35(1):641-648. PubMed ID: 33402521
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
Soni M
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
[TBL] [Abstract][Full Text] [Related]
5. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
[TBL] [Abstract][Full Text] [Related]
6. The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.
Koenderman L; Siemers MJ; van Aalst C; Bongers SH; Spijkerman R; Bindels BJJ; Giustarini G; van Goor HMR; Kaasjager KAH; Vrisekoop N
Cells; 2021 May; 10(5):. PubMed ID: 34062964
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
Front Immunol; 2021; 12():668074. PubMed ID: 34149705
[TBL] [Abstract][Full Text] [Related]
8. Immunological Biomarkers of COVID-19.
Lei R; Mohan C
Crit Rev Immunol; 2020; 40(6):497-512. PubMed ID: 33900694
[TBL] [Abstract][Full Text] [Related]
9. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.
Zhang HJ; Qi GQ; Gu X; Zhang XY; Fang YF; Jiang H; Zhao YJ
Medicine (Baltimore); 2021 Jul; 100(28):e26503. PubMed ID: 34260527
[TBL] [Abstract][Full Text] [Related]
11. Role of eosinophils in the diagnosis and prognostic evaluation of COVID-19.
Tan Y; Zhou J; Zhou Q; Hu L; Long Y
J Med Virol; 2021 Feb; 93(2):1105-1110. PubMed ID: 32915476
[TBL] [Abstract][Full Text] [Related]
12. The role of peripheral blood eosinophil counts in COVID-19 patients.
Xie G; Ding F; Han L; Yin D; Lu H; Zhang M
Allergy; 2021 Feb; 76(2):471-482. PubMed ID: 32562554
[TBL] [Abstract][Full Text] [Related]
13. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
Front Immunol; 2021; 12():626235. PubMed ID: 33584733
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Blood Counts and Markers of Inflammation and Coagulation in Patients With and Without COVID-19 Presenting to the Emergency Department in Seattle, WA.
Chandler CM; Reid MC; Cherian S; Sabath DE; Edlefsen KL
Am J Clin Pathol; 2021 Jul; 156(2):185-197. PubMed ID: 34151348
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.
Seyit M; Avci E; Nar R; Senol H; Yilmaz A; Ozen M; Oskay A; Aybek H
Am J Emerg Med; 2021 Feb; 40():110-114. PubMed ID: 33309506
[TBL] [Abstract][Full Text] [Related]
16. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
[TBL] [Abstract][Full Text] [Related]
17. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
Lin S; Mao W; Zou Q; Lu S; Zheng S
J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
[TBL] [Abstract][Full Text] [Related]
18. Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.
Anurag A; Jha PK; Kumar A
Diabetes Metab Syndr; 2020; 14(6):2099-2102. PubMed ID: 33160224
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.
Rokni M; Ahmadikia K; Asghari S; Mashaei S; Hassanali F
BMC Infect Dis; 2020 Nov; 20(1):869. PubMed ID: 33225909
[TBL] [Abstract][Full Text] [Related]
20. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
